I liked your comment a lot, but I’m pretty sure you misunderstood a big part of the argument because there’s a prettybig typo in this post.
In the original recording(4:07) Fredrich argues that advancing alternative proteins should be a significant part of longtermist thinking, but not that they’re “one of the best ways at making the long-term future go well” or even “on par with AI risk or bioengineered pandemics”.
But this transcript makes it seem like he is saying the opposite in the intro:
“They [alternative proteins] should be the priority...”
I think you still bring up a lot of good points though.
I appreciate your catching this, David—I would not have noticed this and would have been pretty confused by Linch’s comment. I did go back and edit the transcript to align with the video, and I appreciate your noting this.
Edited per your excellent comment that the text flipped the meaning of the video:
The third point is that alternative proteins address multiple risks to long-term flourishing and they should be a priority for longtermists. I’m not going to try to convince you they should be the priority or that they’re on par with AI risk or bioengineered pandemics. But I am going to try to convince you that unless you are working for an organization that is focused on one thing, you should add alternative proteins to your portfolio if you are focused on longtermism.
Also slightly edited this bit to better capture the video:
[16:40] In Toby Ord’s book The Precipice he says, “Risks greater than 1 in 1,000 should be central global priorities.” … my goal is not going to be to convince you [that] if you’re working on unaligned AI or bioengineered pandemics (What are they − 1 in 10 and 1 in 30 existential risks) that this is something that you should do instead. But if you are working in policy… you can have a more diverse portfolio than unaligned AI and bioengineered pandemics. In fact, it’s probably to our benefit to have a more diverse portfolio. And I would contend that alternative proteins should be a part of that portfolio for all of the reasons that I’ve just described...
I liked your comment a lot, but I’m pretty sure you misunderstood a big part of the argument because there’s a pretty big typo in this post.
In the original recording(4:07) Fredrich argues that advancing alternative proteins should be a significant part of longtermist thinking, but not that they’re “one of the best ways at making the long-term future go well” or even “on par with AI risk or bioengineered pandemics”.
But this transcript makes it seem like he is saying the opposite in the intro:
I think you still bring up a lot of good points though.
I appreciate your catching this, David—I would not have noticed this and would have been pretty confused by Linch’s comment. I did go back and edit the transcript to align with the video, and I appreciate your noting this.
Edited per your excellent comment that the text flipped the meaning of the video:
The third point is that alternative proteins address multiple risks to long-term flourishing and they should be a priority for longtermists. I’m not going to try to convince you they should be the priority or that they’re on par with AI risk or bioengineered pandemics. But I am going to try to convince you that unless you are working for an organization that is focused on one thing, you should add alternative proteins to your portfolio if you are focused on longtermism.
Also slightly edited this bit to better capture the video:
[16:40] In Toby Ord’s book The Precipice he says, “Risks greater than 1 in 1,000 should be central global priorities.” … my goal is not going to be to convince you [that] if you’re working on unaligned AI or bioengineered pandemics (What are they − 1 in 10 and 1 in 30 existential risks) that this is something that you should do instead. But if you are working in policy… you can have a more diverse portfolio than unaligned AI and bioengineered pandemics. In fact, it’s probably to our benefit to have a more diverse portfolio. And I would contend that alternative proteins should be a part of that portfolio for all of the reasons that I’ve just described...